Nanoparticulate mineralized collagen scaffolds induce in vivo bone regeneration independent of progenitor cell loading or exogenous growth factor stimulation

Biomaterials

Volumn 89, Issue , 2016, Pages 67-78

  Ren, Xiaoyan ^a,b   Tu, Victor ^a,b   Bischoff, David ^b   Weisgerber, Daniel W ^c   Lewis, Michael S ^b   Yamaguchi, Dean T ^b   Miller, Timothy A ^a,b   Harley, Brendan A C ^c   Lee, Justine C ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Biomimetic material; Bone regeneration; Nanoparticulate mineralization

Indexed keywords

BIOMIMETIC MATERIALS; BIOMIMETICS; BONE; CELL CULTURE; COLLAGEN; STEM CELLS; TISSUE REGENERATION;

BONE REGENERATION; CELLULAR MATERIAL; CRANIAL DEFECTS; EXOGENOUS GROWTH; GROWTH FACTOR; MINERALIZED COLLAGEN; NANO PARTICULATES; PROGENITOR CELL;

SCAFFOLDS (BIOLOGY);

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 9; COLLAGEN; GLYCOSAMINOGLYCAN; GROWTH FACTOR; NANOPARTICULATE MINERALIZED COLLAGEN GLYCOSAMINOGLYCAN SCAFFOLD; UNCLASSIFIED DRUG; BONE MORPHOGENETIC PROTEIN; NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; BONE REGENERATION; CELL CULTURE; CELL DIFFERENTIATION; CELL STIMULATION; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; FRACTURE HEALING; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; RABBIT; SKULL DEFECT; STEM CELL; STEM CELL EXPANSION; ANIMAL; BONE MARROW CELL; BONE PROSTHESIS; CHEMISTRY; CYTOLOGY; DRUG THERAPY; INJURIES; LEPORIDAE; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SKULL; STROMA CELL; TISSUE SCAFFOLD;

ANIMALS; BONE MARROW CELLS; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; BONE SUBSTITUTES; CELLS, CULTURED; COLLAGEN; FRACTURE HEALING; GLYCOSAMINOGLYCANS; NANOPARTICLES; OSTEOGENESIS; RABBITS; SIGNAL TRANSDUCTION; SKULL; STROMAL CELLS; TISSUE SCAFFOLDS;

EID: 84959279532     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2016.02.020     Document Type: Article

References (49)

1. Ebraheim N.A., Elgafy H., Xu R. Bone-graft harvesting from iliac and fibular donor sites: techniques and complications. J. Am. Acad. Orthop. Surg. 2001, 9:210-218.
2. Arrington E.D., Smith W.J., Chambers H.G., Bucknell A.L., Davino N.A. Complications of iliac crest bone graft harvesting. Clin. Orthop. Relat. Res. 1996, 300-309.
3. Ma D., Ren L., Chen F., Liu Y., Zhang J., Xue Z., et al. Reconstruction of rabbit critical-size calvarial defects using autologous bone marrow stromal cell sheets. Ann. Plastic Surg. 2010, 65:259-265.
4. Stocker G., Meyer H.E., Wagener C., Greiling H. Purification and N-terminal amino acid sequence of a chondroitin sulphate/dermatan sulphate proteoglycan isolated from intima/media preparations of human aorta. Biochem. J. 1991, 274(Pt 2):415-420.
5. Lee J.C., Kleiber G.M., Pelletier A.T., Reid R.R., Gottlieb L.J. Autologous immediate cranioplasty with vascularized bone in high-risk composite cranial defects. Plast. Reconstr. Surg. 2013, 132:967-975.
6. Szpalski C., Wetterau M., Barr J., Warren S.M. Bone tissue engineering: current strategies and techniques-part I: Scaffolds. Tissue Eng. Part B Rev. 2012, 18:246-257.
7. Szpalski C., Sagebin F., Barbaro M., Warren S.M. The influence of environmental factors on bone tissue engineering. J. Biomed. Mater Res. B Appl. Biomater. 2013 May, 101(4):663-675.
8. Ducy P., Karsenty G. The family of bone morphogenetic proteins. Kidney Int. 2000, 57:2207-2214.
9. Miyazono K., Kamiya Y., Morikawa M. Bone morphogenetic protein receptors and signal transduction. J. Biochem. 2010, 147:35-51.
10. Kretzschmar M., Doody J., Massagué J. Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1. Nature 1997, 389:618-622.
11. Mukherjee A., Wilson E.M., Rotwein P. Selective signaling by Akt2 promotes bone morphogenetic protein 2-mediated osteoblast differentiation. Mol. Cell Biol. 2010, 30:1018-1027.
12. Li C., Yang X., He Y., Ye G., Li X., Zhang X., et al. Bone morphogenetic protein-9 induces osteogenic differentiation of rat dental follicle stem cells in P38 and ERK1/2 MAPK dependent manner. Int. J. Med. Sci. 2012, 9:862-871.
13. Nolan K., Thompson T.B. The DAN family: Modulators of TGF-β signaling and beyond. Protein Sci. 2014, 23:999-1012.
14. Aspenberg P., Jeppsson C., Economides A.N. The bone morphogenetic proteins antagonist Noggin inhibits membranous ossification. J. Bone Min. Res. 2001, 16:497-500.
15. Gazzerro E., Canalis E. Bone morphogenetic proteins and their antagonists. Rev. Endocr. Metab. Disord. 2006, 7:51-65.
16. Friedlaender G.E. OP-1 clinical studies. J. Bone Jt. Surg. Am. 2001, 83-A(Suppl. 1):S160-S161.
17. Friedlaender G.E., Perry C.R., Cole J.D., Cook S.D., Cierny G., Muschler G.F., et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J. Bone Jt. Surg. Am. 2001, 83-A(Suppl. 1):S151-S158.
18. Khan S.N., Lane J.M. The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in orthopaedic applications. Expert Opin. Biol. Ther. 2004, 4:741-748.
19. Lewandrowski K.U., Nanson C., Calderon R. Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2: a report of five cases. Spine J. 2007, 7:609-614.
20. Smoljanovic T., Bojanic I., Delimar D. Adverse effects of posterior lumbar interbody fusion using rhBMP-2. Eur. Spine J. 2009, 18:920-923. author reply 4.
21. Yee K.S., Nguyen P.D., Andrews B.T., Lee J.C., Bradley J.P. Abstract 4: Decreased Secondary Bone Grafting but Poorer Midface Growth after Primary Alveolar Cleft Repair with Gingivoperiosteoplasty and rhBMP-2. Plast. Reconstr. Surg. 2014, 133:975.
22. Kruger E.A., Im D.D., Bischoff D.S., Pereira C.T., Huang W., Rudkin G.H., et al. In vitro mineralization of human mesenchymal stem cells on three-dimensional type I collagen versus PLGA scaffolds: a comparative analysis. Plast. Reconstr. Surg. 2011, 127:2301-2311.
23. Bergsma E.J., Rozema F.R., Bos R.R., de Bruijn W.C. Foreign body reactions to resorbable poly(L-lactide) bone plates and screws used for the fixation of unstable zygomatic fractures. J. Oral Maxillofac. Surg. 1993, 51:666-670.
24. Jiang W.W., Su S.H., Eberhart R.C., Tang L. Phagocyte responses to degradable polymers. J. Biomed. Mater Res. A 2007, 82:492-497.
25. Walsh W.R., Vizesi F., Michael D., Auld J., Langdown A., Oliver R., et al. Beta-TCP bone graft substitutes in a bilateral rabbit tibial defect model. Biomaterials 2008, 29:266-271.
26. Ren X., Bischoff D., Weisgerber D.W., Lewis M.S., Tu V., Yamaguchi D.T., et al. Osteogenesis on nanoparticulate mineralized collagen scaffolds via autogenous activation of the canonical BMP receptor signaling pathway. Biomaterials 2015, 50:107-114.
27. Lee J.C., Pereira C.T., Ren X., Huang W., Bischoff D., Weisgerber D.W., et al. Optimizing collagen scaffolds for bone engineering: effects of cross-linking and mineral content on structural contraction and osteogenesis. J. Craniofac. Surg. 2015 Sep, 26(6):1992-1996.
28. Harley B.A., Leung J.H., Silva E.C., Gibson L.J. Mechanical characterization of collagen-glycosaminoglycan scaffolds. Acta Biomater. 2007, 3:463-474.
29. Olde Damink L.H., Dijkstra P.J., van Luyn M.J., van Wachem P.B., Nieuwenhuis P., Feijen J. Cross-linking of dermal sheep collagen using a water-soluble carbodiimide. Biomaterials 1996, 17:765-773.
30. Harley B.A., Lynn A.K., Wissner-Gross Z., Bonfield W., Yannas I.V., Gibson L.J. Design of a multiphase osteochondral scaffold II: fabrication of a mineralized collagen-GAG scaffold. J. Biomed. Mater. Res. A 2010, 92:1066-1077.
31. Weisgerber D.W., Kelkhoff D.O., Caliari S.R., Harley B.A.C. The impact of discrete compartments of a multi-compartment collagen-GAG scaffold on overall construct biophysical properties. J. Mech. Behav. Biomed. Mater. 2013, 28:26-36.
32. Ashby E.R., Rudkin G.H., Ishida K., Miller T.A. Evaluation of a novel osteogenic factor, bone cell stimulating substance, in a rabbit cranial defect model. Plast. Reconstr. Surg. 1996, 98:420-426.
33. Caliari S.R., Harley B.A. Structural and biochemical modification of a collagen scaffold to selectively enhance MSC tenogenic, chondrogenic, and osteogenic differentiation. Adv. Healthc. Mater. 2014 Jul, 3(7):1086-1096.
34. Weisgerber D.W., Kelkhoff D.O., Caliari S.R., Harley B.A. The impact of discrete compartments of a multi-compartment collagen-GAG scaffold on overall construct biophysical properties. J. Mech. Behav. Biomed. Mater. 2013, 28:26-36.
35. Roostaeian J., Carlsen B., Simhaee D., Jarrahy R., Huang W., Ishida K., et al. Characterization of growth and osteogenic differentiation of rabbit bone marrow stromal cells. J. Surg. Res. 2006, 133:76-83.
36. Gallant M.A., Brown D.M., Organ J.M., Allen M.R., Burr D.B. Reference-point indentation correlates with bone toughness assessed using whole-bone traditional mechanical testing. Bone 2013, 53:301-305.
37. Diez-Perez A., Güerri R., Nogues X., Cáceres E., Peña M.J., Mellibovsky L., et al. Microindentation for in vivo measurement of bone tissue mechanical properties in humans. J. Bone Min. Res. 2010, 25:1877-1885.
38. Caliari S.R., Mozdzen L.C., Armitage O., Oyen M.L., Harley B.A. Award Winner in the Young Investigator Category, 2014 Society for Biomaterials Annual Meeting and Exposition, Denver, Colorado, April 16-19, 2014: Periodically perforated core-shell collagen biomaterials balance cell infiltration, bioactivity, and mechanical properties. J. Biomed. Mater. Res. A 2014, 102:917-927.
39. Caliari S.R., Ramirez M.A., Harley B.A. The development of collagen-GAG scaffold-membrane composites for tendon tissue engineering. Biomaterials 2011, 32:8990-8998.
40. Rentsch C., Rentsch B., Heinemann S., Bernhardt R., Bischoff B., Förster Y., et al. ECM inspired coating of embroidered 3D scaffolds enhances calvaria bone regeneration. Biomed. Res. Int. 2014, 2014:217078.
41. Opperman L.A., Chhabra A., Nolen A.A., Bao Y., Ogle R.C. Dura mater maintains rat cranial sutures in vitro by regulating suture cell proliferation and collagen production. J. Craniofac. Genet. Dev. Biol. 1998, 18:150-158.
42. Zhao H., Feng J., Ho T.V., Grimes W., Urata M., Chai Y. The suture provides a niche for mesenchymal stem cells of craniofacial bones. Nat. Cell Biol. 2015, 17:386-396.
43. Twine N.A., Chen L., Pang C.N., Wilkins M.R., Kassem M. Identification of differentiation-stage specific markers that define the ex vivo osteoblastic phenotype. Bone 2014, 67:23-32.
44. Rammelt S., Schulze E., Witt M., Petsch E., Biewener A., Pompe W., et al. Collagen type I increases bone remodelling around hydroxyapatite implants in the rat tibia. Cells Tissues Organs 2004, 178:146-157.
45. Manton K.J., Leong D.F., Cool S.M., Nurcombe V. Disruption of heparan and chondroitin sulfate signaling enhances mesenchymal stem cell-derived osteogenic differentiation via bone morphogenetic protein signaling pathways. Stem Cells 2007, 25:2845-2854.
46. Shih Y.R., Hwang Y., Phadke A., Kang H., Hwang N.S., Caro E.J., et al. Calcium phosphate-bearing matrices induce osteogenic differentiation of stem cells through adenosine signaling. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:990-995.
47. Cushnie E.K., Ulery B.D., Nelson S.J., Deng M., Sethuraman S., Doty S.B., et al. Simple signaling molecules for inductive bone regenerative engineering. PLoS One 2014, 9:e101627.
48. Zhu D., Mackenzie N.C., Shanahan C.M., Shroff R.C., Farquharson C., MacRae V.E. BMP-9 regulates the osteoblastic differentiation and calcification of vascular smooth muscle cells through an ALK1 mediated pathway. J. Cell Mol. Med. 2015, 19:165-174.
49. Luu H.H., Song W.X., Luo X., Manning D., Luo J., Deng Z.L., et al. Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. J. Orthop. Res. 2007, 25:665-677.